The U.S. Food and Drug Administration has asked doctors to stop prescribing painkillers that contain more than 325 milligrams of acetaminophen because of reports of severe liver damage. Prescription painkillers, which include Vicodin and ...
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics. Cells become "persisters" by entering a state in which they stop replicating and are able to tolerate ...
Tags: bacterial cells, antibiotics, antibiotic resistance, persister cells
A multi-disciplinary team from the University of Pennsylvania have published in Nature Methods a first-of-its-kind way to isolate RNA from live cells in their natural tissue microenvironment without damaging nearby cells. This allows the ...
Tags: Consumer Electronics, Electronics
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms. In a paper published by the ...
Tags: genetic diseases, RNA, nuclear magnetic resonance spectroscopy
Martin Nielsen, DVM, PhD, Dipl. EVPC, equine parasitologist, veterinarian, and assistant professor at the University of Kentucky (UK) Gluck Equine Research Center, has launched the first research crowdfunding project at UK and possibly the ...
Restricting calorie consumption is one of the few proven ways to combat aging. Though the underlying mechanism is unknown, calorie restriction has been shown to prolong lifespan in yeast, worms, flies, monkeys, and, in some studies, humans. ...
Tags: calorie consumption, aging, calorie restriction, Keren Yizhak, anti-aging
In an early indication of lay opinions on research with induced pluripotent stem cells (iPSCs), which are stem cells made from skin or other tissues, a new study by bioethicists at Johns Hopkins University indicates that despite some ...
Tags: induced pluripotent stem cells, stem cells, Johns Hopkins University
Food and Drug Administration said Monday that it wants makers of antibacterial hand soaps and body washes to prove their products are safe for long-term daily use and more effective than regular soaps in preventing illness and the spread of ...
Tags: antibacterial hand soaps, body washes, FDA
Vector Capital, private equity firm focused on value-oriented investments in technology companies, has sold Certara, a provider of drug development software and services, to Arsenal Capital Partners, a US-based based private equity firm. ...
Tags: Vector Capital, Arsenal Capital
Druggability Technologies (DRGT) has entered into a multi-year collaboration deal with Bayer HealthCare that will deploy DRGT's proprietary Super-API platform to support Bayer HealthCare's formulation efforts directed at enhancing compound ...
Tags: Drugs Discovery, Bayer Healthcare
After 85 years, antibiotics are growing impotent. So what will medicine, agriculture and everyday life look like if we lose these drugs entirely? A few years ago, I started looking online to fill in chapters of my family history that no ...
Tags: imagining, post-antibiotics, future
The ageing of the population is an inevitable world phenomenon which will cause significant changes to society and generate numerous business opportunities that will contribute to the socio-economic development of countries. The ...
Tags: Smart Textiles, Vacuum
France-based NovAliX has entered into a fragment-based drug discovery project with Japanese biopharmaceutical firm Kyowa Hakko Kirin. The deal, which is a continuation of the alliance announced in January 2013, builds upon the positive ...
Alnylam Pharmaceuticals, a RNAi therapeutics company, announced that the US Food and Drug Administration (FDA) has granted fast track designation to patisiran (ALN-TTR02) for the treatment of transthyretin (TTR)-familial amyloid ...
Tags: Alnylam, Fast Track Designation
US-based TransCelerate BioPharma is launching three new global initiatives to further advance efficiency in clinical trials and accelerate the development of new medicines: creation of common clinical trial protocol templates, development ...
Tags: TransCelerate, clinical trial, Global Initiative, Cubist Pharmaceuticals